Vivani Medical, Inc.
NASDAQ:VANIMedical - Devices
+$0.02 today
- Market cap
- $94.71M
- Beta
- 3.29
- P/E (TTM)
- -3.5
- EPS (TTM)
- -$0.33
Volume 0.18M
Average 0.24M
VANI Total Current Assets
All assets expected to be converted to cash or used up within one year.
Vivani Medical, Inc.NASDAQ: VANI
Total Current Assets · Q1 FY2026 · quarter ended Mar 2026
Total current assets rises 45.1% from a year ago
Total current assets stood at $21.55M at the end of Q1 FY2026, up 45.1% from a year earlier and up 20.4% from the prior quarter. Over 3 fiscal years it compounded at -27.8% a year.
Context
- Total current assets amounted to 50.9% of total assets at the end of Q1 FY2026, up 9.0 pp from a year earlier.
- Total current assets increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether total current assets keeps rising in the next quarterly balance sheet after a +45.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Assets history
USD · from the balance sheet
- Latest · FY2025
- 17.9M USD
- Year-over-year change
- -12.4%
- 4-year CAGR
- +64.1%
| Period | Period end | Total Current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 17.9M | -12.4% |
| FY2024 | 2024-12-31 | 20.44M | -11.4% |
| FY2023 | 2023-12-31 | 23.06M | -51.5% |
| FY2022 | 2022-12-31 | 47.53M | +1825.0% |
| FY2021 | 2021-12-31 | 2.47M | — |
Total Current Assets vs competitors
How VANI compares with its peers on the latest reported figures
- Peers report in different currencies, so total current assets is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +45.1% is the 2nd highest of 8, against a peer median of +4.9%.
- Total current assets amounts to 50.9% of total assets for VANI, versus a peer median of 89.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $148.01M USD | +4.9% | +6.8% | 67.5% | |
IMAImageneBio Inc | Mar 2026 | $122.01M USD | +4.3% | -4.3% | 89.3% |
| Mar 2026 | $76.53M USD | +149.6% | +108.4% | 98.0% | |
| Mar 2026 | $68.15M USD | -48.2% | -5.3% | 25.3% | |
| Mar 2026 | $56.03M USD | +15.8% | -26.6% | 92.9% | |
| Mar 2026 | $31.65M USD | -34.0% | -26.0% | 61.4% | |
| Mar 2026 | CA$31.35M CAD | +24.0% | -19.7% | 99.6% | |
| Mar 2026 | $21.55M USD | +45.1% | -27.8% | 50.9% | |
| Peer median (excluding VANI) | — | +4.9% | -5.3% | 89.3% | |
Competitors are the stored peer set for VANI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Vivani Medical, Inc.
NASDAQ:VANI
Intrinsic Alpha fair value
Locked
Current Price
$1.05
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.